secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K/A
Filed at:   2023-08-31T23:59:59+00:00
Accession:  0001437749-23-024952
Event type: other_material
Sentiment:  negative
Materiality: 0.50
Item codes: 2.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pieris adds $3.4M retention & severance costs to July 2023 restructuring estimate
--------------------------------------------------------------------------------

- Compensation Committee approved retention benefits for non-executive employees on Aug 30, 2023.
- Total estimated retention, severance and related costs now ~$3.4M through Q2 2024.
- This amount is in addition to severance costs originally reported in the July 18, 2023 8-K.
- Amendment filed solely to update cost estimates; no other changes to prior disclosures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000143774923024952/0001437749-23-024952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000143774923024952/pirs20230823c_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-024952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer